Cargando…

Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds

Breast cancers are highly heterogeneous and their metastatic potential and response to therapeutic drugs is difficult to predict. A tool that could accurately gauge tumour invasiveness and drug response would provide a valuable addition to the oncologist’s arsenal. We have developed a 3-dimensional...

Descripción completa

Detalles Bibliográficos
Autores principales: Hume, Robert D., Pensa, Sara, Brown, Elizabeth J., Kreuzaler, Peter A., Hitchcock, Jessica, Husmann, Anke, Campbell, Jonathan J., Lloyd-Thomas, Annabel O., Cameron, Ruth E., Watson, Christine J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107500/
https://www.ncbi.nlm.nih.gov/pubmed/30139956
http://dx.doi.org/10.1038/s41598-018-30107-3
_version_ 1783349974555164672
author Hume, Robert D.
Pensa, Sara
Brown, Elizabeth J.
Kreuzaler, Peter A.
Hitchcock, Jessica
Husmann, Anke
Campbell, Jonathan J.
Lloyd-Thomas, Annabel O.
Cameron, Ruth E.
Watson, Christine J.
author_facet Hume, Robert D.
Pensa, Sara
Brown, Elizabeth J.
Kreuzaler, Peter A.
Hitchcock, Jessica
Husmann, Anke
Campbell, Jonathan J.
Lloyd-Thomas, Annabel O.
Cameron, Ruth E.
Watson, Christine J.
author_sort Hume, Robert D.
collection PubMed
description Breast cancers are highly heterogeneous and their metastatic potential and response to therapeutic drugs is difficult to predict. A tool that could accurately gauge tumour invasiveness and drug response would provide a valuable addition to the oncologist’s arsenal. We have developed a 3-dimensional (3D) culture model that recapitulates the stromal environment of breast cancers by generating anisotropic (directional) collagen scaffolds seeded with adipocytes and culturing tumour fragments therein. Analysis of tumour cell invasion in the presence of various therapeutic drugs, by immunofluorescence microscopy coupled with an optical clearing technique, demonstrated the utility of this approach in determining both the rate and capacity of tumour cells to migrate through the stroma while shedding light also on the mode of migration. Furthermore, the response of different murine mammary tumour types to chemotherapeutic drugs could be readily quantified.
format Online
Article
Text
id pubmed-6107500
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61075002018-08-28 Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds Hume, Robert D. Pensa, Sara Brown, Elizabeth J. Kreuzaler, Peter A. Hitchcock, Jessica Husmann, Anke Campbell, Jonathan J. Lloyd-Thomas, Annabel O. Cameron, Ruth E. Watson, Christine J. Sci Rep Article Breast cancers are highly heterogeneous and their metastatic potential and response to therapeutic drugs is difficult to predict. A tool that could accurately gauge tumour invasiveness and drug response would provide a valuable addition to the oncologist’s arsenal. We have developed a 3-dimensional (3D) culture model that recapitulates the stromal environment of breast cancers by generating anisotropic (directional) collagen scaffolds seeded with adipocytes and culturing tumour fragments therein. Analysis of tumour cell invasion in the presence of various therapeutic drugs, by immunofluorescence microscopy coupled with an optical clearing technique, demonstrated the utility of this approach in determining both the rate and capacity of tumour cells to migrate through the stroma while shedding light also on the mode of migration. Furthermore, the response of different murine mammary tumour types to chemotherapeutic drugs could be readily quantified. Nature Publishing Group UK 2018-08-23 /pmc/articles/PMC6107500/ /pubmed/30139956 http://dx.doi.org/10.1038/s41598-018-30107-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Hume, Robert D.
Pensa, Sara
Brown, Elizabeth J.
Kreuzaler, Peter A.
Hitchcock, Jessica
Husmann, Anke
Campbell, Jonathan J.
Lloyd-Thomas, Annabel O.
Cameron, Ruth E.
Watson, Christine J.
Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds
title Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds
title_full Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds
title_fullStr Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds
title_full_unstemmed Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds
title_short Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds
title_sort tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3d engineered anisotropic collagen scaffolds
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107500/
https://www.ncbi.nlm.nih.gov/pubmed/30139956
http://dx.doi.org/10.1038/s41598-018-30107-3
work_keys_str_mv AT humerobertd tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds
AT pensasara tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds
AT brownelizabethj tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds
AT kreuzalerpetera tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds
AT hitchcockjessica tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds
AT husmannanke tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds
AT campbelljonathanj tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds
AT lloydthomasannabelo tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds
AT cameronruthe tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds
AT watsonchristinej tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds